Wipe the vial stopper with an alcohol swab before inserting the needle
Do not use GLP-1 treatments if: Warnings and Precautions: Pregnancy and Reproductive Health: GLP-1 medications may cause harm to a fetus and should not be used during pregnancy or when planning to become pregnant
A: No legitimate, regulated form of retatrutide is available to the general public
[1] Commonly prescribed GLP-1 agonists include semaglutide (Ozempic for diabetes, Wegovy for weight management), dulaglutide (Trulicity), liraglutide (Victoza for diabetes, Saxenda for weight management), and exenatide (Byetta, Bydureon)
However, this must be done with close monitoring by a rheumatologist, as disease activity can change over time
The medication is currently being studied in the TRIUMPH Phase 3 clinical trial program, which is typically the final stage of testing before companies apply for FDA approval